Randomized Comparison of the CHOlesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant patientS - The CHOLESS Trial

Trial Profile

Randomized Comparison of the CHOlesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant patientS - The CHOLESS Trial

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Nutraceuticals
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions
  • Acronyms CHOLESS
  • Most Recent Events

    • 15 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top